<div style="margin-bottom: 10px;">
                      <a href=https://www.sec.gov/Archives/edgar/data/1140859/000114085923000077/abc-20230309.htm>Download 8-K Special Filing Report</a>
                    </div>
                    <div>
                      <a href=https://www.sec.gov/Archives/edgar/data/1140859/000114085923000077/0001140859-23-000077-index.htm>Original filing index</a>
                    </div>

XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

Form 8-K - Current report - Item 5.07 Item 8.01

Amerisource Bergen Corp.

Announcement: ABC 8-K Special Filing

<div style="margin-bottom: 10px;">
                      <a href=https://www.sec.gov/Archives/edgar/data/1140859/000114085923000027/abc-20221231.htm>Download 10-Q Quarterly Report</a>
                    </div>
                    <div>
                      <a href=https://www.sec.gov/Archives/edgar/data/1140859/000114085923000027/0001140859-23-000027-index.htm>Original filing index</a>
                    </div>

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

AmerisourceBergen Corp. Reports Improved Q4 Results
Current Analysis:
AmerisourceBergen Corp. reported its fourth quarter results showing a 5.4% increase in revenue from the prior year quarter due to growth in their U.S. Healthcare Solutions segment. Gross profit increased by 4.4% from the prior year quarter. The increase was driven by an increase in gross profit in U.S. Healthcare Solutions and gains from antitrust litigation settlements. Selling, general, and administrative expenses increased by 0.2% from the prior year quarter primarily due to higher marketing, legal, and professional fees, partially offset by lower acquisition-related costs.

Forward-Looking Analysis:
AmerisourceBergen Corp. plans to change its name to Cencora in the second half of 2023. The new name represents a unified presence that will continue to fuel their ongoing growth strategy and advance their impact across healthcare. Additionally, the acquisition of PharmaLex Holding Gmbh will advance their role as a partner of choice for biopharmaceutical partners across the pharmaceutical development and commercialization journey. Going forward, AmerisourceBergen Corp. will be well-positioned to capitalize on the growing demand for pharmaceuticals and healthcare products, both domestically and internationally. They are also well-positioned to benefit from the increasing trend of outsourcing services in the pharmaceutical industry, as well as the trend towards personalized and

Announcement: ABC 10-Q Quarterly Report

<div style="margin-bottom: 10px;">
                      <a href=https://www.sec.gov/Archives/edgar/data/1140859/000114085923000025/abc-20230201.htm>Download 8-K Special Filing Report</a>
                    </div>
                    <div>
                      <a href=https://www.sec.gov/Archives/edgar/data/1140859/000114085923000025/0001140859-23-000025-index.htm>Original filing index</a>
                    </div>

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

<div style="margin-bottom: 10px;">
                          <a href=https://www.sec.gov/Archives/edgar/data/1140859/000114085923000021/abc-20230123.htm>Download 8-K Special Filing Report</a>
                        </div>
                        <div>
                          <a href=https://www.sec.gov/Archives/edgar/data/1140859/000114085923000021/0001140859-23-000021-index.htm>Original filing index</a>
                        </div>

<div style="margin-bottom: 10px;">
                          <a href=https://www.sec.gov/Archives/edgar/data/1140859/000110465923005999/tm234123d1_8k.htm>Download 8-K Special Filing Report</a>
                        </div>
                        <div>
                          <a href=https://www.sec.gov/Archives/edgar/data/1140859/000110465923005999/0001104659-23-005999-index.htm>Original filing index</a>
                        </div>

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

Form 8-K - Current report - Item 7.01 Item 9.01

<div style="margin-bottom: 10px;">
                          <a href=https://www.sec.gov/Archives/edgar/data/1140859/000110465923000085/tm2233673d1_8k.htm>Download 8-K Special Filing Report</a>
                        </div>
                        <div>
                          <a href=https://www.sec.gov/Archives/edgar/data/1140859/000110465923000085/0001104659-23-000085-index.htm>Original filing index</a>
                        </div>

Form 8-K - Current report - Item 8.01 Item 9.01